Wedemeyer H - Search Results

1

Peptide-beta2-microglobulin-MHC fusion molecules bind antigen-specific T cells and can be used for multivalent MHC-Ig complexes.

Greten TF, Korangy F, Neumann G, Wedemeyer H, Schlote K, Heller A, Scheffer S, Pardoll DM, Garbe AI, Schneck JP, Manns MP. Greten TF, et al. Among authors: wedemeyer h. J Immunol Methods. 2002 Dec 20;271(1-2):125-35. doi: 10.1016/s0022-1759(02)00346-0. J Immunol Methods. 2002. PMID: 12445736

2

Treatment of chronic hepatitis C with PEGylated interferon and ribavirin.

Cornberg M, Wedemeyer H, Manns MP. Cornberg M, et al. Among authors: wedemeyer h. Curr Gastroenterol Rep. 2002 Feb;4(1):23-30. doi: 10.1007/s11894-002-0034-y. Curr Gastroenterol Rep. 2002. PMID: 11825538 Review.

3

Polyethylene glycol-interferon: current status in hepatitis C virus therapy.

Wedemeyer H, Wiegand J, Cornberg M, Manns MP. Wedemeyer H, et al. J Gastroenterol Hepatol. 2002 Dec;17 Suppl 3:S344-50. doi: 10.1046/j.1440-1746.17.s3.26.x. J Gastroenterol Hepatol. 2002. PMID: 12472962 Review.

4

Autoimmune hepatitis and overlap syndromes.

Vogel A, Wedemeyer H, Manns MP, Strassburg CP. Vogel A, et al. Among authors: wedemeyer h. J Gastroenterol Hepatol. 2002 Dec;17 Suppl 3:S389-98. doi: 10.1046/j.1440-1746.17.s3.33.x. J Gastroenterol Hepatol. 2002. PMID: 12472969 Review.

5

Inhibition of hepatitis B virus replication in vivo by nucleoside analogues and siRNA.

Klein C, Bock CT, Wedemeyer H, Wüstefeld T, Locarnini S, Dienes HP, Kubicka S, Manns MP, Trautwein C. Klein C, et al. Among authors: wedemeyer h. Gastroenterology. 2003 Jul;125(1):9-18. doi: 10.1016/s0016-5085(03)00720-0. Gastroenterology. 2003. PMID: 12851866

6

A rare manifestation of Behçet's syndrome: immunological correlates and successful treatment of an esophageal ulcer.

Wedemeyer H, Kuipers JG, Streetz K, Mengel M, Schedel I, Kezmic N, Meier P, Zeidler H, Manns MP, Wagner S. Wedemeyer H, et al. Dig Dis Sci. 2003 Jul;48(7):1385-91. doi: 10.1023/a:1024183931726. Dig Dis Sci. 2003. PMID: 12870801 No abstract available.

7

The German network of excellence for viral hepatitis (Hep-Net).

Manns MP, Meyer S, Wedemeyer H. Manns MP, et al. Among authors: wedemeyer h. Hepatology. 2003 Sep;38(3):543-4. doi: 10.1002/hep.510380302. Hepatology. 2003. PMID: 12939578 No abstract available.

8

Treatment of hepatitis B in special patient groups: hemodialysis, heart and renal transplant, fulminant hepatitis, hepatitis B virus reactivation.

Tillmann HL, Wedemeyer H, Manns MP. Tillmann HL, et al. Among authors: wedemeyer h. J Hepatol. 2003;39 Suppl 1:S206-11. doi: 10.1016/s0168-8278(03)00364-7. J Hepatol. 2003. PMID: 14708705 Review. No abstract available.

9

Hepatitis B virus: where are we and where are we going?

Manns MP, Hadem J, Wedemeyer H. Manns MP, et al. Among authors: wedemeyer h. Methods Mol Med. 2004;96:415-43. doi: 10.1385/1-59259-670-3:415. Methods Mol Med. 2004. PMID: 14762285 Review. No abstract available.

10

High rate of spontaneous clearance of acute hepatitis C virus genotype 3 infection.

Lehmann M, Meyer MF, Monazahian M, Tillmann HL, Manns MP, Wedemeyer H. Lehmann M, et al. Among authors: wedemeyer h. J Med Virol. 2004 Jul;73(3):387-91. doi: 10.1002/jmv.20103. J Med Virol. 2004. PMID: 15170633

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

794 results

Search Page